Clinical features of thrombosis and bleeding in COVID-19
MR Thomas, M Scully - Blood, The Journal of the American …, 2022 - ashpublications.org
Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
[HTML][HTML] The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
M Xiang, X Wu, H Jing, VA Novakovic… - Frontiers in …, 2023 - frontiersin.org
The role of hypoxia, vascular endothelial injury, and thrombotic inflammation in worsening
COVID-19 symptoms has been generally recognized. Damaged vascular endothelium plays …
COVID-19 symptoms has been generally recognized. Damaged vascular endothelium plays …
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of …
Abstract Background: COVID-19–related acute illness is associated with an increased risk of
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19
Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …
controversial. In addition, the association of vaccination with COVID-19–related VTE and …
Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: COVID-PACT
Background: The efficacy and safety of prophylactic full-dose anticoagulation and
antiplatelet therapy in critically ill COVID-19 patients remain uncertain. Methods: COVID …
antiplatelet therapy in critically ill COVID-19 patients remain uncertain. Methods: COVID …
Thromboprophylaxis in patients with COVID-19: a brief update to the CHEST guideline and expert panel report
Background Patients hospitalized with COVID-19 often exhibit markers of a hypercoagulable
state and have an increased incidence of VTE. In response, CHEST issued rapid clinical …
state and have an increased incidence of VTE. In response, CHEST issued rapid clinical …
Randomized trials of therapeutic heparin for COVID‐19: a meta‐analysis
Background Pulmonary endothelial injury and microcirculatory thromboses likely contribute
to hypoxemic respiratory failure, the most common cause of death, in patients with COVID …
to hypoxemic respiratory failure, the most common cause of death, in patients with COVID …
Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …
Short and long-term impact of COVID-19 infection on previous respiratory diseases
E Chiner-Vives, R Cordovilla-Perez… - Archivos de …, 2022 - Elsevier
Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …
COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment
L Ortega-Paz, AH Talasaz… - … in thrombosis and …, 2022 - thieme-connect.com
COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …